Bruker Corporation (BRKR)

Market Cap	5.01B
Revenue (ttm)	3.44B
Net Income (ttm)	79.60M
Shares Out	151.72M
EPS (ttm)	0.52
PE Ratio	63.42
Forward PE	15.24
Dividend	$0.20 (0.61%)
Ex-Dividend Date	Sep 23, 2025

Volume	19,873
Open	32.64
Previous Close	32.36
Day's Range	32.62 - 32.83
52-Week Range	30.00 - 72.94
Beta	1.16
Analysts	Buy
Price Target	50.00 (+51.29%)
Earnings Date	Aug 4, 2025

About BRKR

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 4, 2000
• Employees: 11,396
• Stock Exchange: NASDAQ
• Ticker Symbol: BRKR
• Website: https://www.bruker.com

Financial Performance

In 2024, Bruker's revenue was $3.37 billion, an increase of 13.56% compared to the previous year's $2.96 billion. Earnings were $113.10 million, a decrease of -73.53%.

Analyst Forecast

According to 11 analysts, the average rating for BRKR stock is "Buy." The 12-month stock price target is $50.0, which is an increase of 51.29% from the latest price.

Price Target

$50.0

(51.29% upside)

Analyst Consensus: Buy